Windtree Therapeutics announces 1-for-18 reverse stock split effective April 19, 2024

WINDTREE THERAPEUTICS INC /DE/

Board set reverse split ratio at 1-for-18; effective 11:59 p.m. ET on April 19, 2024.
Common stock to trade split-adjusted on Nasdaq under symbol WINT starting April 22, 2024; new CUSIP 97382D 501.
No fractional shares issued; holders entitled to a fractional share will receive one whole share instead.
Proportional adjustments to conversion prices of 10% senior convertible notes due 2025 and Series B convertible preferred, and to exercise prices of stock options and warrants.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

WINDTREE THERAPEUTICS INC /DE/: Effected a 1-for-18 reverse stock split of common stock via amendment to the Amended and Restated Certificate of Incorporation (effective 2024-04-19).

Change: charter amendment
Effective: 2024-04-19

Exact text from the filing

On April 19, 2024, the Company filed the Amendment for the Reverse Stock Split with the Secretary of State of the State of Delaware, and the Reverse Stock Split will become effective in accordance with the terms of the Amendment at 11:59 p.m. Eastern Time on April 19, 2024

View on SEC.gov

274 governance changes filed in the last 30 days. Browse all governance changes →

WINDTREE THERAPEUTICS INC /DE/ filing history →

Source: SEC EDGAR

accession 0001437749-24-012577

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.